Modality
Gene Therapy
MOA
TROP-2 ADC
Target
C5
Pathway
Wnt
MCCNBCKD
Development Pipeline
Preclinical
~Apr 2011
→ ~Jul 2012
Phase 1
~Oct 2012
→ ~Jan 2014
Phase 2
~Apr 2014
→ ~Jul 2015
Phase 3
~Oct 2015
→ ~Jan 2017
NDA/BLA
~Apr 2017
→ ~Jul 2018
Approved
Oct 2018
→ Nov 2030
ApprovedCurrent
NCT03848008
1,865 pts·NB
2018-10→2030-11·Terminated
1,865 total pts1 indication
CompletedCurrentUpcoming
Catalysts (1)
2030-11-114.6y awayPh3 Readout· NB
Trial Timeline
Q42019Q2Q3Q42020Q2Q3Q42021Q2Q3Q42022Q2Q3Q42023Q2Q3Q42024Q2Q3Q42025Q2Q3Q42026Q2Q3Q42027Q2Q3Q42028Q2Q3Q42029Q2Q3Q42030Q2Q3Q4
Approved
Termina…
Catalysts
Ph3 Readout
2030-11-11 · 4.6y away
NB
Terminated|StartCompletionToday
Trials (1)
| NCT | Phase | Indication | Status | N | EP |
|---|---|---|---|---|---|
| NCT03848008 | Approved | NB | Terminated | 1865 | eGFR |
Competitors (10)